SmartWinnr has launched a specialised medical simulation Center of Excellence (CoE) to strengthen the accuracy, relevance and compliance readiness of its AI-driven learning solutions for the pharmaceutical and medtech sectors. The company currently works with over 70+ life sciences organisations across more than 30 countries.

The new centre brings together experienced life sciences professionals and AI specialists to ensure that every simulation reflects real-world medical conversations and field conditions. It is designed to continuously enhance SmartWinnr’s AI systems with deep clinical knowledge, therapeutic insights, behavioural science and frontline sales experience. The goal is to build AI that understands the scientific, emotional and ethical dimensions that shape how customer-facing teams engage with healthcare professionals.

SmartWinnr’s approach places human expertise at the core of AI development. Former pharma leaders, medical experts and training specialists work continuously to train, validate and refine the simulations. Their involvement ensures that the AI responds with the same complexity, precision and empathy expected in real healthcare interactions.

The system is trained across two critical dimensions. First, it is coached to think like a healthcare professional by raising authentic questions, objections and concerns that arise in clinical discussions. Second, it is trained to evaluate the performance of medical representatives and deliver clear, actionable feedback that drives measurable improvement. During pilot deployments, customers reported an improvement of 35 percent in representative confidence and 45 percent in message recall.

By combining deep human expertise with advanced generative AI, SmartWinnr is redefining how life sciences companies prepare their field teams. The simulations now reflect not only scientific accuracy, but also the responsibility, confidence and clarity required in real medical engagements. This allows customer-facing teams to practice in a safe environment while strengthening their ability to communicate with accuracy and impact.

Speaking on the initiative, Keats K Das, Chief of Staff and Director of Sales, SmartWinnr, said, “We decided to invest in domain-specific AI because that is where meaningful intelligence truly begins. Generic models can simulate conversations, but they cannot fully understand the science, context or compliance responsibilities that define how pharma and medtech teams interact with healthcare professionals. Our goal is to build AI that communicates with accuracy, empathy and regulatory awareness.”

With the launch of the medical simulation CoE, SmartWinnr strengthens its commitment to developing responsible and industry-ready AI for the life sciences sector. Over the next year, the company plans to scale the centre with 20+ additional medical experts and expand coverage across all major therapy areas in life sciences.

Das added, “Our vision goes beyond automation. We are creating AI that continuously learns from real human expertise. By embedding medical, behavioral and compliance insights into every simulation, we are helping life sciences organisations achieve what traditional digital learning often misses. That is authenticity, confidence and measurable readiness for every medical representative in the field.”